The Korean journal of internal medicine

  • 제32권4호
  • /
  • Pages.699-710
  • /
  • 2017
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

The pattern of choosing dialysis modality and related mortality outcomes in Korea: a national population-based study

  • Kim, Hyung Jong (Department of Internal Medicine, CHA Bundang Medical Center, CHA University) ;
  • Park, Jung Tak (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Han, Seung Hyeok (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Yoo, Tae-Hyun (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Park, Hyeong-Cheon (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kang, Shin-Wook (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Kyoung Hoon (Department of Public Health, Korea University Graduate School) ;
  • Ryu, Dong-Ryeol (Department of Internal Medicine, Tissue Injury Defense Research Center, Ewha Womans University School of Medicine) ;
  • Kim, Hyunwook (Department of Internal Medicine, Yonsei University College of Medicine)
  • 투고 : 2017.03.16
  • 심사 : 2017.06.14
  • 발행 : 2017.07.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: Since comorbidities are major determinants of modality choice, and also interact with dialysis modality on mortality outcomes, we examined the pattern of modality choice according to comorbidities and then evaluated how such choices affected mortality in incident dialysis patients. Methods: We analyzed 32,280 incident dialysis patients in Korea. Patterns in initial dialysis choice were assessed by multivariate logistic regression analyses. Multivariate Poisson regression analyses were performed to evaluate the effects of interactions between comorbidities and dialysis modality on mortality and to quantify these interactions using the synergy factor. Results: Prior histories of myocardial infarction (p = 0.031), diabetes (p = 0.001), and congestive heart failure (p = 0.003) were independent factors favoring the initiation with peritoneal dialysis (PD), but were associated with increased mortality with PD. In contrast, a history of cerebrovascular disease and 1-year increase in age favored initiation with hemodialysis (HD) and were related to a survival benefit with HD (p < 0.001, both). While favoring initiation with HD, having Medical Aid (p = 0.001) and male gender (p = 0.047) were related to increased mortality with HD. Furthermore, although the severity of comorbidities did not inf luence dialysis modality choice, mortality in incident PD patients was significantly higher compared to that in HD patients as the severity of comorbidities increased (p for trend < 0.001). Conclusions: Some comorbidities exerted independent effects on initial choice of dialysis modality, but this choice did not always lead to the best results. Further analyses of the pattern of choosing dialysis modality according to baseline comorbid conditions and related consequent mortality outcomes are needed.

키워드

참고문헌

  1. ESRD in the United States: an overview of USRDS annual data report volume 2. Am J Kidney Dis 2015;66(1 Suppl 1):S79-S92. https://doi.org/10.1053/j.ajkd.2015.04.025
  2. van de Luijtgaarden MW, Jager KJ, Stel VS, et al. Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators. Nephrol Dial Transplant 2013;28:1264-1275. https://doi.org/10.1093/ndt/gft053
  3. Stack AG. Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol 2002;13:1279-1287.
  4. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003;14:415-424. https://doi.org/10.1097/01.ASN.0000043140.23422.4F
  5. Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003;64:1071-1079. https://doi.org/10.1046/j.1523-1755.2003.00165.x
  6. van de Luijtgaarden MW, Noordzij M, Stel VS, et al. Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe. Nephrol Dial Transplant 2011;26:2940-2947. https://doi.org/10.1093/ndt/gfq845
  7. Ryu JH, Kim H, Kim KH, et al. Improving survival rate of Korean patients initiating dialysis. Yonsei Med J 2015;56:666-675. https://doi.org/10.3349/ymj.2015.56.3.666
  8. Kim H, Kim KH, Park K, et al. A population-based approach indicates an overall higher patient mortality with peritoneal dialysis compared to hemodialysis in Korea. Kidney Int 2014;86:991-1000. https://doi.org/10.1038/ki.2014.163
  9. Kim H, Kim KH, Ahn SV, et al. Risk of major cardiovascular events among incident dialysis patients: a Korean national population-based study. Int J Cardiol 2015;198:95-101. https://doi.org/10.1016/j.ijcard.2015.06.120
  10. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011;171:110-118.
  11. van de Luijtgaarden MW, Jager KJ, Segelmark M, et al. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. Nephrol Dial Transplant 2016;31:120-128. https://doi.org/10.1093/ndt/gfv295
  12. Noordzij M, Jager KJ. Patient survival on dialysis in Korea: a different story? Kidney Int 2014;86:877-880. https://doi.org/10.1038/ki.2014.194
  13. Cortina-Borja M, Smith AD, Combarros O, Lehmann DJ. The synergy factor: a statistic to measure interactions in complex diseases. BMC Res Notes 2009;2:105. https://doi.org/10.1186/1756-0500-2-105
  14. Kim JH, Lee KS, Yoo KB, Park EC. The differences in health care utilization between Medical Aid and health insurance: a longitudinal study using propensity score matching. PLoS One 2015;10:e0119939. https://doi.org/10.1371/journal.pone.0119939
  15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383. https://doi.org/10.1016/0021-9681(87)90171-8
  16. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-1139. https://doi.org/10.1097/01.mlr.0000182534.19832.83
  17. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004;66:2389-2401. https://doi.org/10.1111/j.1523-1755.2004.66028.x
  18. Miskulin DC, Meyer KB, Athienites NV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 2002;39:324-336. https://doi.org/10.1053/ajkd.2002.30552
  19. Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 2012;27:3568-3575. https://doi.org/10.1093/ndt/gfr674
  20. de Jager DJ, Grootendorst DC, Jager KJ, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009;302:1782-1789. https://doi.org/10.1001/jama.2009.1488
  21. Liem YS, Wong JB, Hunink MG, de Charro FT, Winkelmayer WC. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int 2007;71:153-158. https://doi.org/10.1038/sj.ki.5002014
  22. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? Kidney Int Suppl 2006;(103):S3-S11.
  23. Couchoud C, Bolignano D, Nistor I, et al. Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence. Nephrol Dial Transplant 2015;30:310-320. https://doi.org/10.1093/ndt/gfu293
  24. Gotloib L, Fudin R, Yakubovich M, Vienken J. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 2005;20 Suppl 7:vii32-vii36. https://doi.org/10.1093/ndt/gfh1105
  25. Koch M, Haastert B, Kohnle M, et al. Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease. Eur J Heart Fail 2012;14:530-539. https://doi.org/10.1093/eurjhf/hfs035
  26. Selby NM, McIntyre CW. Peritoneal dialysis is not associated with myocardial stunning. Perit Dial Int 2011;31:27-33. https://doi.org/10.3747/pdi.2010.00007
  27. Sens F, Schott-Pethelaz AM, Labeeuw M, Colin C, Villar E; REIN Registry. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney Int 2011;80:970-977. https://doi.org/10.1038/ki.2011.233
  28. Liu J, Rosner MH. Lipid abnormalities associated with end-stage renal disease. Semin Dial 2006;19:32-40. https://doi.org/10.1111/j.1525-139X.2006.00117.x
  29. Kronenberg F, Konig P, Neyer U, et al. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995;6:110-120.
  30. Konings CJ, Kooman JP, Schonck M, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002;22:477-487.
  31. Plum J, Schoenicke G, Kleophas W, et al. Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transplant 2001;16:2378-2385. https://doi.org/10.1093/ndt/16.12.2378
  32. Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K, Heimburger O. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000;11:1303-1309.
  33. Holmes C, Mujais S. Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int Suppl 2006;(103):S104-S109.
  34. Collins AJ, Hao W, Xia H, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999;34:1065-1074. https://doi.org/10.1016/S0272-6386(99)70012-0
  35. Han SS, Park JY, Kang S, et al. Dialysis modality and mortality in the elderly: a meta-analysis. Clin J Am Soc Nephrol 2015;10:983-993. https://doi.org/10.2215/CJN.05160514
  36. Bronnum-Hansen H, Davidsen M, Thorvaldsen P; Danish MONICA Study Group. Long-term survival and causes of death after stroke. Stroke 2001;32:2131-2136. https://doi.org/10.1161/hs0901.094253
  37. Nadeau-Fredette AC, Johnson DW, Hawley CM, et al. Center-specific factors associated with peritonitis risk-a multi-center registry analysis. Perit Dial Int 2016;36:509-518. https://doi.org/10.3747/pdi.2015.00146
  38. Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996;7:2176-2182.
  39. Jaar BG, Coresh J, Plantinga LC, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005;143:174-183. https://doi.org/10.7326/0003-4819-143-3-200508020-00003
  40. Sanabria M, Munoz J, Trillos C, et al. Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia. Kidney Int Suppl 2008;(108):S165-S172.
  41. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009;20:155-163. https://doi.org/10.1681/ASN.2007111188
  42. Chang YK, Hsu CC, Hwang SJ, et al. A comparative assessment of survival between propensity score-matched patients with peritoneal dialysis and hemodialysis in Taiwan. Medicine (Baltimore) 2012;91:144-151. https://doi.org/10.1097/MD.0b013e318256538e
  43. Just PM, de Charro FT, Tschosik EA, Noe LL, Bhattacharyya SK, Riella MC. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 2008;23:2365-2373. https://doi.org/10.1093/ndt/gfm939

피인용 문헌

  1. Efficiency of Brazilian public services of kidney transplantation: Benchmarking Brazilian states via data envelopment analysis vol.33, pp.4, 2017, https://doi.org/10.1002/hpm.2588
  2. Comparative study of peritoneal dialysis versus hemodialysis on the clinical outcomes in Korea: a population-based approach vol.9, pp.None, 2019, https://doi.org/10.1038/s41598-019-42508-z
  3. Comparison of peritoneal dialysis with hemodialysis on survival of diabetic patients with end-stage kidney disease: a meta-analysis of cohort studies vol.41, pp.1, 2017, https://doi.org/10.1080/0886022x.2019.1625788
  4. Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis vol.53, pp.7, 2017, https://doi.org/10.1007/s11255-020-02683-9
  5. Comparison of shared decision making in patients undergoing hemodialysis and peritoneal dialysis for choosing a dialysis modality vol.22, pp.1, 2017, https://doi.org/10.1186/s12882-021-02269-2